• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人高分子量激肽原。血浆接触激活过程中分子的结构-功能关系及蛋白水解研究。

Human high molecular weight kininogen. Studies of structure-function relationships and of proteolysis of the molecule occurring during contact activation of plasma.

作者信息

Kerbiriou D M, Griffin J H

出版信息

J Biol Chem. 1979 Dec 10;254(23):12020-7.

PMID:500690
Abstract

Human high Mr kininogen was purified from normal plasma in 35% yield. The purified high Mr kininogen appeared homogeneous on polyacrylamide gels in the presence of sodium dodecyl sulfate and mercaptoethanol and gave a single protein band with an apparent Mr = 110,000. Using sedimentation equilibrium techniques, the observed Mr was 108,000 +/- 2,000. Human plasma kallikrein cleaves high Mr kininogen to liberate kinin and give a kinin-free, two-chain, disulfide-linked molecule containing a heavy chain of apparent Mr = 65,000 and a light chain of apparent Mr = 44,000. The light chain is histidine-rich and exhibits a high affinity for negatively charged materials. The isolated alkylated light chain quantitatively retains the procoagulant activity of the single-chain parent molecule. 125I-Human high Mr kininogen undergoes cleavage in plasma during contact activation initiated by addition of kaolin. This cleavage, which liberates kinin and gives a two-chain, disulfide-linked molecule, is dependent upon the presence of prekallikrein and Factor XII (Hageman factor) in plasma. Addition of purified plasma kallikrein to normal plasma or to plasmas deficient in prekallikrein or Factor XII in the presence or absence of kaolin results in cleavage of high Mr kininogen and kinin formation.

摘要

人高分子量激肽原从正常血浆中纯化得到,产率为35%。纯化后的高分子量激肽原在十二烷基硫酸钠和巯基乙醇存在的情况下,在聚丙烯酰胺凝胶上呈现均一性,给出一条表观分子量为110,000的单一蛋白条带。使用沉降平衡技术,观察到的分子量为108,000±2,000。人血浆激肽释放酶裂解高分子量激肽原以释放激肽,并产生一个不含激肽的、由二硫键连接的双链分子,该分子包含一条表观分子量为65,000的重链和一条表观分子量为44,000的轻链。轻链富含组氨酸,对带负电荷的物质表现出高亲和力。分离得到的烷基化轻链定量保留了单链亲本分子的促凝活性。125I-人高分子量激肽原在加入高岭土引发的接触激活过程中在血浆中发生裂解。这种裂解释放激肽并产生一个由二硫键连接的双链分子,其依赖于血浆中前激肽释放酶和因子Ⅻ(哈格曼因子)的存在。在有或没有高岭土存在的情况下,向正常血浆或缺乏前激肽释放酶或因子Ⅻ的血浆中加入纯化的血浆激肽释放酶会导致高分子量激肽原的裂解和激肽的形成。

相似文献

1
Human high molecular weight kininogen. Studies of structure-function relationships and of proteolysis of the molecule occurring during contact activation of plasma.人高分子量激肽原。血浆接触激活过程中分子的结构-功能关系及蛋白水解研究。
J Biol Chem. 1979 Dec 10;254(23):12020-7.
2
Kinin release from high molecular weight kininogen by the action of Hageman factor in the absence of kallikrein.在没有激肽释放酶的情况下,通过Hageman因子的作用从高分子量激肽原释放激肽。
J Biol Chem. 1983 Jul 25;258(14):8963-70.
3
Rat plasma high-molecular-weight kininogen. A simple method for purification and its characterization.大鼠血浆高分子量激肽原。一种纯化及其特性鉴定的简单方法。
J Biol Chem. 1985 May 25;260(10):6115-23.
4
Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.人高分子量激肽原的裂解显著增强其凝血活性。该分子作为前辅因子存在的证据。
J Clin Invest. 1984 Apr;73(4):954-62. doi: 10.1172/JCI111319.
5
Contact activation of plasma: structure-activity relationships of human high molecular weight kininogen.血浆的接触激活:人高分子量激肽原的构效关系
Adv Exp Med Biol. 1979;120B:153-61.
6
Immunochemical studies of human high molecular weight kininogen and of its complexes with plasma prekallikrein or kallikrein.人高分子量激肽原及其与血浆前激肽释放酶或激肽释放酶复合物的免疫化学研究。
J Biol Chem. 1980 May 10;255(9):3952-8.
7
The role of bovine high-molecular-weight (HMW) kininogen in contact-mediated activation of bovine factor XII: interaction of HMW kininogen with kaolin and plasma prekallikrein.牛高分子量(HMW)激肽原在接触介导的牛因子XII激活中的作用:HMW激肽原与高岭土和血浆前激肽释放酶的相互作用。
J Biochem. 1981 Jun;89(6):1699-709. doi: 10.1093/oxfordjournals.jbchem.a133370.
8
Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions.表面介导的牛因子XII和前激肽释放酶激活的动力学研究。高岭土和高分子量激肽原对激活反应的影响。
Eur J Biochem. 1985 Jan 2;146(1):43-50. doi: 10.1111/j.1432-1033.1985.tb08617.x.
9
High-molecular-weight kininogen from horse plasma. Isolation, characterization and comparison with bovine high-Mr kininogen.马血浆中的高分子量激肽原。分离、特性鉴定及与牛高分子量激肽原的比较。
Eur J Biochem. 1981 Apr;115(3):439-47.
10
The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.接触激活过程中人类凝血因子Ⅻ的结合与裂解特性。正常血浆与缺乏因子Ⅺ、前激肽释放酶或高分子量激肽原的血浆的比较。
J Clin Invest. 1977 Jun;59(6):1167-75. doi: 10.1172/JCI108741.

引用本文的文献

1
Kininogen enhances seizure susceptibility in mice possibly through bradykinin-induced modulation of calcium transients in glutamatergic and GABAergic neurons.激肽原可能通过缓激肽诱导的谷氨酸能和γ-氨基丁酸能神经元钙瞬变调节来增强小鼠的癫痫易感性。
Front Pharmacol. 2025 Jun 10;16:1509837. doi: 10.3389/fphar.2025.1509837. eCollection 2025.
2
High Molecular Weight Kininogen: A Review of the Structural Literature.高分子量激肽原:结构文献综述。
Int J Mol Sci. 2021 Dec 13;22(24):13370. doi: 10.3390/ijms222413370.
3
Polyphosphate expression by cancer cell extracellular vesicles mediates binding of factor XII and contact activation.
癌细胞细胞外囊泡表达多磷酸盐介导凝血因子 XII 的结合和接触激活。
Blood Adv. 2021 Nov 23;5(22):4741-4751. doi: 10.1182/bloodadvances.2021005116.
4
Proteomic Alterations in Multiple Myeloma: A Comprehensive Study Using Bone Marrow Interstitial Fluid and Serum Samples.多发性骨髓瘤的蛋白质组学改变:一项使用骨髓间质液和血清样本的综合研究
Front Oncol. 2021 Jan 29;10:566804. doi: 10.3389/fonc.2020.566804. eCollection 2020.
5
Mapping of type 2 diabetes proteins to COVID-19 biomarkers: A proteomic analysis.2型糖尿病蛋白与新冠病毒生物标志物的映射关系:蛋白质组学分析
Metabol Open. 2020 Dec 13;9:100074. doi: 10.1016/j.metop.2020.100074. eCollection 2021 Mar.
6
Biological network inferences for a protection mechanism against familial Creutzfeldt-Jakob disease with E200K pathogenic mutation.针对 E200K 致病性突变的家族性克雅氏病保护机制的生物网络推断。
BMC Med Genomics. 2014 Aug 22;7:52. doi: 10.1186/1755-8794-7-52.
7
Investigation of an albumin-enriched fraction of human serum and its albuminome.人血清富含白蛋白组分及其白蛋白组的研究。
Proteomics Clin Appl. 2007 Jan 1;1(1):73-88. doi: 10.1002/prca.200600276.
8
Ferritin binds to light chain of human H-kininogen and inhibits kallikrein-mediated bradykinin release.铁蛋白与人H-激肽原轻链结合并抑制激肽释放酶介导的缓激肽释放。
Biochem J. 2002 Jul 1;365(Pt 1):279-86. doi: 10.1042/BJ20011637.
9
Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII.热休克蛋白90在缺乏因子XII的情况下催化前激肽释放酶-激肽原复合物的激活。
Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):896-900. doi: 10.1073/pnas.022626899. Epub 2002 Jan 15.
10
Streptococcal cysteine proteinase releases kinins: a virulence mechanism.链球菌半胱氨酸蛋白酶释放激肽:一种致病机制。
J Exp Med. 1996 Aug 1;184(2):665-73. doi: 10.1084/jem.184.2.665.